Alkermes plc
ALKS
Hisse Senetlerindeki Sıralama
#2726
Alkermes plc, a biopharmaceutical company, engages in the research,... Alkermes plc, a biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally. The company has a portfolio of proprietary commercial products for the treatment of opioid dependence, alcohol dependence, schizophrenia, bipolar I, and a pipeline of clinical and preclinical product candidates in development for neurological disorders. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ARISTADA INITIO for the treatment of schizophrenia in adults; VIVITROL for the treatment of alcohol and prevention of opioid dependence; LYBALVI, an oral atypical antipsychotic drug candidate for the treatment of adults with schizophrenia and bipolar I disorder; and LUMRYZ, an extended-release oral suspension product for the treatment of cataplexy or EDS in pediatric patients. The company also offers proprietary technology platforms to third parties to enable them to develop, commercialize, and manufacture products. It has collaboration agreements primarily with Janssen Pharmaceutica N.V., Janssen Pharmaceutica Inc, and Janssen Pharmaceutica International. Alkermes plc was founded in 1987 and is headquartered in Dublin, Ireland.
Hisse Fiyatı
$41.39
Son senkronizasyon: 2026-10-16
Piyasa Değeri
$6.94B
Değişim (1 gün)
3.22%
Değişim (1 yıl)
36.78%
Ülke
IE
Ticaret Alkermes plc (ALKS)
Kategori
Healthcare
Alkermes plc (ALKS) için EPS
June 2026 itibariyle EPS TTM: $0.40
Alkermes plc şirketinin en son finansal raporlarına ve hisse senedi fiyatına göre, şirketin mevcut EPS'si (TTM) $0.40'dir. 2023 yılı sonunda, şirketin EPS'si $2.14 idi; bu, 2022 yılındaki EPS olan $-0.97 ile önceki yıla göre artış.
Alkermes plc için 2000 - 2026 arasındaki EPS geçmişi
Her yıl sonunda EPS
| Yıl | EPS | Değiştir |
|---|---|---|
| 2026 (TTM) | $0.40 | -81.98% |
| 2024 | $2.22 | 3.74% |
| 2023 | $2.14 | -320.62% |
| 2022 | $-0.97 | 223.33% |
| 2021 | $-0.30 | -57.14% |
| 2020 | $-0.70 | -44.00% |
| 2019 | $-1.25 | 38.89% |
| 2018 | $-0.90 | -12.62% |
| 2017 | $-1.03 | -25.36% |
| 2016 | $-1.38 | -9.21% |
| 2015 | $-1.52 | 623.81% |
| 2014 | $-0.21 | -210.53% |
| 2013 | $0.19 | 0.00% |
| 2012 | $0.19 | -119.19% |
| 2011 | $-0.99 | 106.25% |
| 2010 | $-0.48 | 14.29% |
| 2009 | $-0.42 | -130.66% |
| 2008 | $1.37 | -17.47% |
| 2007 | $1.66 | 1,560.00% |
| 2006 | $0.10 | 150.00% |
| 2005 | $0.04 | -104.82% |
| 2004 | $-0.83 | -33.60% |
| 2003 | $-1.25 | -26.47% |
| 2002 | $-1.70 | 77.08% |
| 2001 | $-0.96 | 123.26% |
| 2000 | $-0.43 | 0.00% |
Benzer şirketler veya rakipler için EPS
| Şirket | EPS | EPS Farkı | Ülke |
|---|---|---|---|
| $17.32 | 4,230.00% |
US
|
|
| $-7.98 | -2,095.00% |
US
|
|
| $-5.29 | -1,422.50% |
AU
|
|
| - | - |
CH
|
|
| $27.74 | 6,835.00% |
NL
|
